Abbott Nutrition Sales Decline but Show Sequential Improvement
Dow Jones
Jul 16
Abbott's Nutrition segment reported a 3.1% sales decline in the second quarter, with comparable sales down 3.6%. The company attributes the drop to lower sales volumes compared to the prior year and strategic pricing actions implemented in the fourth quarter of 2025. U.S. Pediatric Nutrition fell 10.7%, while international pediatric sales rose 7.3%. There's a sequential uptick, however: Nutrition sales increased $127 million from the first quarter of 2026. Abbott says the pricing actions and new product launches are contributing to improving performance
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
(END) Dow Jones Newswires
July 16, 2026 08:19 ET (12:19 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.